| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |